(Q33900485)

29 July 2017

title

Regulatory effects of IFN-β on the development of experimental autoimmune uveoretinitis in B10RIII mice (English)

1 reference

29 July 2017

6

Aize Kijlstra

1 reference

29 July 2017

Min Sun

1

1 reference

29 July 2017

Yan Yang

2

1 reference

29 July 2017

Peizeng Yang

3

1 reference

29 July 2017

Bo Lei

4

1 reference

29 July 2017

Liping Du

5

1 reference

29 July 2017

language of work or name

English

0 references

publication date

6 May 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

6

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

e19870

1 reference

Creative Commons Attribution 4.0 International

29 July 2017

copyright license

start time

6 May 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

Interferon-alpha: a therapeutic target in systemic lupus erythematosus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

Visualization of IFNbeta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

Severe dermatomyositis triggered by interferon beta-1a therapy and associated with enhanced type I interferon signaling

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

Role of Th1 and Th17 cells in organ-specific autoimmunity.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

Experimental autoimmune uveoretinitis in the rat and mouse

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

Laser acceleration of quasi-monoenergetic MeV ion beams.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

Issues in T-helper 1 development--resolved and unresolved

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.

5 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019870

Immune regulatory properties and interactions of copolymer-I and beta-interferon 1a in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019870

IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019870

IFN-beta inhibits human Th17 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019870

Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019870

The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019870

IL-10 has a protective role in experimental autoimmune uveoretinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019870

The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019870

IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019870

Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019870

A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3089639

Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development

29 October 2018

1 reference

12 December 2020

Differential roles for IFN- and IL-17 in experimental autoimmune uveoretinitis

1 reference

12 December 2020

Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis

1 reference

12 December 2020

Interferon alpha 2a in IRPB-derived peptide-induced EAU--part I

1 reference

12 December 2020

Effect of type I interferon on experimental autoimmune uveoretinitis in rats

1 reference

12 December 2020

Shifting therapeutic attention in MS to osteopontin, type 1 and type 2 IFN

1 reference

12 December 2020

Autoimmune inflammation from the Th17 perspective

1 reference

12 December 2020

Interferon beta induces T-helper 2 immune deviation in MS

1 reference

12 December 2020

Therapy: Behçet uveitis: good results for IFN-alpha-2a

1 reference

12 December 2020

Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis

1 reference

12 December 2020

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

12 December 2020

Beta interferon restricts the inflammatory potential of CD4+ cells through the boost of the Th2 phenotype, the inhibition of Th17 response and the prevalence of naturally occurring T regulatory cells

1 reference

12 December 2020

Oral administration of interferon-beta suppresses experimental autoimmune uveoretinitis

1 reference

12 December 2020

The effects of interferon-beta on interleukin-10 in multiple sclerosis patients

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0019870

Identifiers

DOI

1 reference

29 July 2017

0 references

1 reference

29 July 2017

1 reference